- Posts:
- 1 (0.024 per day)
- Personal Text:
- Members self-administered day by day subcutaneous injections of tesamorelin (Theratechnologies Inc), a stabilized analogue of human GHRH (1 mg/d), or placebo 30 minutes before bedtime for 20 weeks. Treatment with GHRH elevated fasting insulin levels ins
- Age:
- N/A
- Location:
- France, Vigneux-Sur-Seine
- Date Registered:
- October 17, 2025, 10:17:42 AM
- Local Time:
- November 28, 2025, 05:29:55 PM
- Last Active:
- October 17, 2025, 10:18:54 AM
Signature:
Members self-administered day by day subcutaneous injections of tesamorelin (Theratechnologies Inc), a stabilized analogue of human GHRH (1 mg/d), or placebo 30 minutes before bedtime for 20 weeks.References:
dev.dhf.icu

